Doximity's New CFO Just Filed His First Form 4. Here's What Long-Term Investors Should Know.

Doximity's new CFO Matthew Sonefeldt sold 15,311 shares worth $380,000 in a non-discretionary transaction tied to restricted stock unit vesting and tax obligations. The sale reduced his holdings by only 3%, leaving him with a $12.1 million equity stake. The filing comes as the company faces slowing growth with Q3 guidance at only 1% growth midpoint, tight pharma spending, and margin pressure from AI compute costs, though management expects improvement in Q3 when AI search revenue lands.